Global PD-L1 Biomarker Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global PD-L1 Biomarker Testing market size was valued at USD 1513.1 million in 2023 and is forecast to a readjusted size of USD 13730 million by 2030 with a CAGR of 37.0% during review period.
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to 'trick' the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PDL1 testing is used to find out if you have a cancer that may benefit from immunotherapy.
The classification of PD-L1 Biomarker Testing includes PD-L1 (22C3), PD-L1 (28-8), PD-L1 (SP142), PD-L1 (SP263) and Other, and the revenue proportion of PD-L1 (22C3) in 2019 is about 21.68%.
PD-L1 Biomarker Testing is widely used in Hospital and Diagnostic Laboratories. The most proportion of PD-L1 Biomarker Testing is Hospital, and the proportion in 2019 is about 52.7%.
North Americas is the largest consumption place, with a consumption market share nearly 55.63% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 26.7%.
The Global Info Research report includes an overview of the development of the PD-L1 Biomarker Testing industry chain, the market status of Hospital (PD-L1 (22C3), PD-L1(28-8)), Diagnostic Center (PD-L1 (22C3), PD-L1(28-8)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of PD-L1 Biomarker Testing.
Regionally, the report analyzes the PD-L1 Biomarker Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global PD-L1 Biomarker Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the PD-L1 Biomarker Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the PD-L1 Biomarker Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., PD-L1 (22C3), PD-L1(28-8)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the PD-L1 Biomarker Testing market.
Regional Analysis: The report involves examining the PD-L1 Biomarker Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the PD-L1 Biomarker Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to PD-L1 Biomarker Testing:
Company Analysis: Report covers individual PD-L1 Biomarker Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards PD-L1 Biomarker Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Diagnostic Center).
Technology Analysis: Report covers specific technologies relevant to PD-L1 Biomarker Testing. It assesses the current state, advancements, and potential future developments in PD-L1 Biomarker Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the PD-L1 Biomarker Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
PD-L1 Biomarker Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe PD-L1 Biomarker Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of PD-L1 Biomarker Testing, with revenue, gross margin and global market share of PD-L1 Biomarker Testing from 2019 to 2024.
Chapter 3, the PD-L1 Biomarker Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and PD-L1 Biomarker Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of PD-L1 Biomarker Testing.
Chapter 13, to describe PD-L1 Biomarker Testing research findings and conclusion.
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to 'trick' the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PDL1 testing is used to find out if you have a cancer that may benefit from immunotherapy.
The classification of PD-L1 Biomarker Testing includes PD-L1 (22C3), PD-L1 (28-8), PD-L1 (SP142), PD-L1 (SP263) and Other, and the revenue proportion of PD-L1 (22C3) in 2019 is about 21.68%.
PD-L1 Biomarker Testing is widely used in Hospital and Diagnostic Laboratories. The most proportion of PD-L1 Biomarker Testing is Hospital, and the proportion in 2019 is about 52.7%.
North Americas is the largest consumption place, with a consumption market share nearly 55.63% in 2019. Following North Americas, Europe is the second largest consumption place with the consumption market share of 26.7%.
The Global Info Research report includes an overview of the development of the PD-L1 Biomarker Testing industry chain, the market status of Hospital (PD-L1 (22C3), PD-L1(28-8)), Diagnostic Center (PD-L1 (22C3), PD-L1(28-8)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of PD-L1 Biomarker Testing.
Regionally, the report analyzes the PD-L1 Biomarker Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global PD-L1 Biomarker Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the PD-L1 Biomarker Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the PD-L1 Biomarker Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., PD-L1 (22C3), PD-L1(28-8)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the PD-L1 Biomarker Testing market.
Regional Analysis: The report involves examining the PD-L1 Biomarker Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the PD-L1 Biomarker Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to PD-L1 Biomarker Testing:
Company Analysis: Report covers individual PD-L1 Biomarker Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards PD-L1 Biomarker Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Diagnostic Center).
Technology Analysis: Report covers specific technologies relevant to PD-L1 Biomarker Testing. It assesses the current state, advancements, and potential future developments in PD-L1 Biomarker Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the PD-L1 Biomarker Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
PD-L1 Biomarker Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- PD-L1 (22C3)
- PD-L1(28-8)
- PD-L1 (SP142)
- PD-L1 (SP263)
- Other
- Hospital
- Diagnostic Center
- Others
- Agilent Technologies
- Roche
- Merck
- Bristol-Myers Squibb
- AstraZeneca
- Ono Pharmaceutical
- Regeneron
- Innovent
- Hengrui Medicine
- Junshi Biosciences
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe PD-L1 Biomarker Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of PD-L1 Biomarker Testing, with revenue, gross margin and global market share of PD-L1 Biomarker Testing from 2019 to 2024.
Chapter 3, the PD-L1 Biomarker Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and PD-L1 Biomarker Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of PD-L1 Biomarker Testing.
Chapter 13, to describe PD-L1 Biomarker Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of PD-L1 Biomarker Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of PD-L1 Biomarker Testing by Type
1.3.1 Overview: Global PD-L1 Biomarker Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global PD-L1 Biomarker Testing Consumption Value Market Share by Type in 2023
1.3.3 PD-L1 (22C3)
1.3.4 PD-L1(28-8)
1.3.5 PD-L1 (SP142)
1.3.6 PD-L1 (SP263)
1.3.7 Other
1.4 Global PD-L1 Biomarker Testing Market by Application
1.4.1 Overview: Global PD-L1 Biomarker Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Diagnostic Center
1.4.4 Others
1.5 Global PD-L1 Biomarker Testing Market Size & Forecast
1.6 Global PD-L1 Biomarker Testing Market Size and Forecast by Region
1.6.1 Global PD-L1 Biomarker Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global PD-L1 Biomarker Testing Market Size by Region, (2019-2030)
1.6.3 North America PD-L1 Biomarker Testing Market Size and Prospect (2019-2030)
1.6.4 Europe PD-L1 Biomarker Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific PD-L1 Biomarker Testing Market Size and Prospect (2019-2030)
1.6.6 South America PD-L1 Biomarker Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa PD-L1 Biomarker Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business
2.1.3 Agilent Technologies PD-L1 Biomarker Testing Product and Solutions
2.1.4 Agilent Technologies PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Agilent Technologies Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche PD-L1 Biomarker Testing Product and Solutions
2.2.4 Roche PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck PD-L1 Biomarker Testing Product and Solutions
2.3.4 Merck PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Product and Solutions
2.4.4 Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca PD-L1 Biomarker Testing Product and Solutions
2.5.4 AstraZeneca PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 AstraZeneca Recent Developments and Future Plans
2.6 Ono Pharmaceutical
2.6.1 Ono Pharmaceutical Details
2.6.2 Ono Pharmaceutical Major Business
2.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Product and Solutions
2.6.4 Ono Pharmaceutical PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Ono Pharmaceutical Recent Developments and Future Plans
2.7 Regeneron
2.7.1 Regeneron Details
2.7.2 Regeneron Major Business
2.7.3 Regeneron PD-L1 Biomarker Testing Product and Solutions
2.7.4 Regeneron PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Regeneron Recent Developments and Future Plans
2.8 Innovent
2.8.1 Innovent Details
2.8.2 Innovent Major Business
2.8.3 Innovent PD-L1 Biomarker Testing Product and Solutions
2.8.4 Innovent PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Innovent Recent Developments and Future Plans
2.9 Hengrui Medicine
2.9.1 Hengrui Medicine Details
2.9.2 Hengrui Medicine Major Business
2.9.3 Hengrui Medicine PD-L1 Biomarker Testing Product and Solutions
2.9.4 Hengrui Medicine PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hengrui Medicine Recent Developments and Future Plans
2.10 Junshi Biosciences
2.10.1 Junshi Biosciences Details
2.10.2 Junshi Biosciences Major Business
2.10.3 Junshi Biosciences PD-L1 Biomarker Testing Product and Solutions
2.10.4 Junshi Biosciences PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Junshi Biosciences Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global PD-L1 Biomarker Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of PD-L1 Biomarker Testing by Company Revenue
3.2.2 Top 3 PD-L1 Biomarker Testing Players Market Share in 2023
3.2.3 Top 6 PD-L1 Biomarker Testing Players Market Share in 2023
3.3 PD-L1 Biomarker Testing Market: Overall Company Footprint Analysis
3.3.1 PD-L1 Biomarker Testing Market: Region Footprint
3.3.2 PD-L1 Biomarker Testing Market: Company Product Type Footprint
3.3.3 PD-L1 Biomarker Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global PD-L1 Biomarker Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global PD-L1 Biomarker Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global PD-L1 Biomarker Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global PD-L1 Biomarker Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America PD-L1 Biomarker Testing Consumption Value by Type (2019-2030)
6.2 North America PD-L1 Biomarker Testing Consumption Value by Application (2019-2030)
6.3 North America PD-L1 Biomarker Testing Market Size by Country
6.3.1 North America PD-L1 Biomarker Testing Consumption Value by Country (2019-2030)
6.3.2 United States PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
6.3.3 Canada PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe PD-L1 Biomarker Testing Consumption Value by Type (2019-2030)
7.2 Europe PD-L1 Biomarker Testing Consumption Value by Application (2019-2030)
7.3 Europe PD-L1 Biomarker Testing Market Size by Country
7.3.1 Europe PD-L1 Biomarker Testing Consumption Value by Country (2019-2030)
7.3.2 Germany PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
7.3.3 France PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
7.3.5 Russia PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
7.3.6 Italy PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region
8.3.1 Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Region (2019-2030)
8.3.2 China PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
8.3.3 Japan PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
8.3.5 India PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
8.3.7 Australia PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America PD-L1 Biomarker Testing Consumption Value by Type (2019-2030)
9.2 South America PD-L1 Biomarker Testing Consumption Value by Application (2019-2030)
9.3 South America PD-L1 Biomarker Testing Market Size by Country
9.3.1 South America PD-L1 Biomarker Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country
10.3.1 Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
10.3.4 UAE PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 PD-L1 Biomarker Testing Market Drivers
11.2 PD-L1 Biomarker Testing Market Restraints
11.3 PD-L1 Biomarker Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 PD-L1 Biomarker Testing Industry Chain
12.2 PD-L1 Biomarker Testing Upstream Analysis
12.3 PD-L1 Biomarker Testing Midstream Analysis
12.4 PD-L1 Biomarker Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of PD-L1 Biomarker Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of PD-L1 Biomarker Testing by Type
1.3.1 Overview: Global PD-L1 Biomarker Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global PD-L1 Biomarker Testing Consumption Value Market Share by Type in 2023
1.3.3 PD-L1 (22C3)
1.3.4 PD-L1(28-8)
1.3.5 PD-L1 (SP142)
1.3.6 PD-L1 (SP263)
1.3.7 Other
1.4 Global PD-L1 Biomarker Testing Market by Application
1.4.1 Overview: Global PD-L1 Biomarker Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Diagnostic Center
1.4.4 Others
1.5 Global PD-L1 Biomarker Testing Market Size & Forecast
1.6 Global PD-L1 Biomarker Testing Market Size and Forecast by Region
1.6.1 Global PD-L1 Biomarker Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global PD-L1 Biomarker Testing Market Size by Region, (2019-2030)
1.6.3 North America PD-L1 Biomarker Testing Market Size and Prospect (2019-2030)
1.6.4 Europe PD-L1 Biomarker Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific PD-L1 Biomarker Testing Market Size and Prospect (2019-2030)
1.6.6 South America PD-L1 Biomarker Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa PD-L1 Biomarker Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Agilent Technologies
2.1.1 Agilent Technologies Details
2.1.2 Agilent Technologies Major Business
2.1.3 Agilent Technologies PD-L1 Biomarker Testing Product and Solutions
2.1.4 Agilent Technologies PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Agilent Technologies Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche PD-L1 Biomarker Testing Product and Solutions
2.2.4 Roche PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck PD-L1 Biomarker Testing Product and Solutions
2.3.4 Merck PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Product and Solutions
2.4.4 Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca PD-L1 Biomarker Testing Product and Solutions
2.5.4 AstraZeneca PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 AstraZeneca Recent Developments and Future Plans
2.6 Ono Pharmaceutical
2.6.1 Ono Pharmaceutical Details
2.6.2 Ono Pharmaceutical Major Business
2.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Product and Solutions
2.6.4 Ono Pharmaceutical PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Ono Pharmaceutical Recent Developments and Future Plans
2.7 Regeneron
2.7.1 Regeneron Details
2.7.2 Regeneron Major Business
2.7.3 Regeneron PD-L1 Biomarker Testing Product and Solutions
2.7.4 Regeneron PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Regeneron Recent Developments and Future Plans
2.8 Innovent
2.8.1 Innovent Details
2.8.2 Innovent Major Business
2.8.3 Innovent PD-L1 Biomarker Testing Product and Solutions
2.8.4 Innovent PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Innovent Recent Developments and Future Plans
2.9 Hengrui Medicine
2.9.1 Hengrui Medicine Details
2.9.2 Hengrui Medicine Major Business
2.9.3 Hengrui Medicine PD-L1 Biomarker Testing Product and Solutions
2.9.4 Hengrui Medicine PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Hengrui Medicine Recent Developments and Future Plans
2.10 Junshi Biosciences
2.10.1 Junshi Biosciences Details
2.10.2 Junshi Biosciences Major Business
2.10.3 Junshi Biosciences PD-L1 Biomarker Testing Product and Solutions
2.10.4 Junshi Biosciences PD-L1 Biomarker Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Junshi Biosciences Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global PD-L1 Biomarker Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of PD-L1 Biomarker Testing by Company Revenue
3.2.2 Top 3 PD-L1 Biomarker Testing Players Market Share in 2023
3.2.3 Top 6 PD-L1 Biomarker Testing Players Market Share in 2023
3.3 PD-L1 Biomarker Testing Market: Overall Company Footprint Analysis
3.3.1 PD-L1 Biomarker Testing Market: Region Footprint
3.3.2 PD-L1 Biomarker Testing Market: Company Product Type Footprint
3.3.3 PD-L1 Biomarker Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global PD-L1 Biomarker Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global PD-L1 Biomarker Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global PD-L1 Biomarker Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global PD-L1 Biomarker Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America PD-L1 Biomarker Testing Consumption Value by Type (2019-2030)
6.2 North America PD-L1 Biomarker Testing Consumption Value by Application (2019-2030)
6.3 North America PD-L1 Biomarker Testing Market Size by Country
6.3.1 North America PD-L1 Biomarker Testing Consumption Value by Country (2019-2030)
6.3.2 United States PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
6.3.3 Canada PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe PD-L1 Biomarker Testing Consumption Value by Type (2019-2030)
7.2 Europe PD-L1 Biomarker Testing Consumption Value by Application (2019-2030)
7.3 Europe PD-L1 Biomarker Testing Market Size by Country
7.3.1 Europe PD-L1 Biomarker Testing Consumption Value by Country (2019-2030)
7.3.2 Germany PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
7.3.3 France PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
7.3.5 Russia PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
7.3.6 Italy PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region
8.3.1 Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Region (2019-2030)
8.3.2 China PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
8.3.3 Japan PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
8.3.5 India PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
8.3.7 Australia PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America PD-L1 Biomarker Testing Consumption Value by Type (2019-2030)
9.2 South America PD-L1 Biomarker Testing Consumption Value by Application (2019-2030)
9.3 South America PD-L1 Biomarker Testing Market Size by Country
9.3.1 South America PD-L1 Biomarker Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country
10.3.1 Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
10.3.4 UAE PD-L1 Biomarker Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 PD-L1 Biomarker Testing Market Drivers
11.2 PD-L1 Biomarker Testing Market Restraints
11.3 PD-L1 Biomarker Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 PD-L1 Biomarker Testing Industry Chain
12.2 PD-L1 Biomarker Testing Upstream Analysis
12.3 PD-L1 Biomarker Testing Midstream Analysis
12.4 PD-L1 Biomarker Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global PD-L1 Biomarker Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global PD-L1 Biomarker Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global PD-L1 Biomarker Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global PD-L1 Biomarker Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies Major Business
Table 7. Agilent Technologies PD-L1 Biomarker Testing Product and Solutions
Table 8. Agilent Technologies PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Agilent Technologies Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche PD-L1 Biomarker Testing Product and Solutions
Table 13. Roche PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Recent Developments and Future Plans
Table 15. Merck Company Information, Head Office, and Major Competitors
Table 16. Merck Major Business
Table 17. Merck PD-L1 Biomarker Testing Product and Solutions
Table 18. Merck PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Merck Recent Developments and Future Plans
Table 20. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 21. Bristol-Myers Squibb Major Business
Table 22. Bristol-Myers Squibb PD-L1 Biomarker Testing Product and Solutions
Table 23. Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Bristol-Myers Squibb Recent Developments and Future Plans
Table 25. AstraZeneca Company Information, Head Office, and Major Competitors
Table 26. AstraZeneca Major Business
Table 27. AstraZeneca PD-L1 Biomarker Testing Product and Solutions
Table 28. AstraZeneca PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. AstraZeneca Recent Developments and Future Plans
Table 30. Ono Pharmaceutical Company Information, Head Office, and Major Competitors
Table 31. Ono Pharmaceutical Major Business
Table 32. Ono Pharmaceutical PD-L1 Biomarker Testing Product and Solutions
Table 33. Ono Pharmaceutical PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Ono Pharmaceutical Recent Developments and Future Plans
Table 35. Regeneron Company Information, Head Office, and Major Competitors
Table 36. Regeneron Major Business
Table 37. Regeneron PD-L1 Biomarker Testing Product and Solutions
Table 38. Regeneron PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Regeneron Recent Developments and Future Plans
Table 40. Innovent Company Information, Head Office, and Major Competitors
Table 41. Innovent Major Business
Table 42. Innovent PD-L1 Biomarker Testing Product and Solutions
Table 43. Innovent PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Innovent Recent Developments and Future Plans
Table 45. Hengrui Medicine Company Information, Head Office, and Major Competitors
Table 46. Hengrui Medicine Major Business
Table 47. Hengrui Medicine PD-L1 Biomarker Testing Product and Solutions
Table 48. Hengrui Medicine PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Hengrui Medicine Recent Developments and Future Plans
Table 50. Junshi Biosciences Company Information, Head Office, and Major Competitors
Table 51. Junshi Biosciences Major Business
Table 52. Junshi Biosciences PD-L1 Biomarker Testing Product and Solutions
Table 53. Junshi Biosciences PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Junshi Biosciences Recent Developments and Future Plans
Table 55. Global PD-L1 Biomarker Testing Revenue (USD Million) by Players (2019-2024)
Table 56. Global PD-L1 Biomarker Testing Revenue Share by Players (2019-2024)
Table 57. Breakdown of PD-L1 Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in PD-L1 Biomarker Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key PD-L1 Biomarker Testing Players
Table 60. PD-L1 Biomarker Testing Market: Company Product Type Footprint
Table 61. PD-L1 Biomarker Testing Market: Company Product Application Footprint
Table 62. PD-L1 Biomarker Testing New Market Entrants and Barriers to Market Entry
Table 63. PD-L1 Biomarker Testing Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global PD-L1 Biomarker Testing Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global PD-L1 Biomarker Testing Consumption Value Share by Type (2019-2024)
Table 66. Global PD-L1 Biomarker Testing Consumption Value Forecast by Type (2025-2030)
Table 67. Global PD-L1 Biomarker Testing Consumption Value by Application (2019-2024)
Table 68. Global PD-L1 Biomarker Testing Consumption Value Forecast by Application (2025-2030)
Table 69. North America PD-L1 Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America PD-L1 Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America PD-L1 Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America PD-L1 Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America PD-L1 Biomarker Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America PD-L1 Biomarker Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe PD-L1 Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe PD-L1 Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe PD-L1 Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe PD-L1 Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe PD-L1 Biomarker Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe PD-L1 Biomarker Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America PD-L1 Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America PD-L1 Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America PD-L1 Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America PD-L1 Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America PD-L1 Biomarker Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America PD-L1 Biomarker Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 99. PD-L1 Biomarker Testing Raw Material
Table 100. Key Suppliers of PD-L1 Biomarker Testing Raw Materials
Table 1. Global PD-L1 Biomarker Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global PD-L1 Biomarker Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global PD-L1 Biomarker Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global PD-L1 Biomarker Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Agilent Technologies Company Information, Head Office, and Major Competitors
Table 6. Agilent Technologies Major Business
Table 7. Agilent Technologies PD-L1 Biomarker Testing Product and Solutions
Table 8. Agilent Technologies PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Agilent Technologies Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche PD-L1 Biomarker Testing Product and Solutions
Table 13. Roche PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Recent Developments and Future Plans
Table 15. Merck Company Information, Head Office, and Major Competitors
Table 16. Merck Major Business
Table 17. Merck PD-L1 Biomarker Testing Product and Solutions
Table 18. Merck PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Merck Recent Developments and Future Plans
Table 20. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 21. Bristol-Myers Squibb Major Business
Table 22. Bristol-Myers Squibb PD-L1 Biomarker Testing Product and Solutions
Table 23. Bristol-Myers Squibb PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Bristol-Myers Squibb Recent Developments and Future Plans
Table 25. AstraZeneca Company Information, Head Office, and Major Competitors
Table 26. AstraZeneca Major Business
Table 27. AstraZeneca PD-L1 Biomarker Testing Product and Solutions
Table 28. AstraZeneca PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. AstraZeneca Recent Developments and Future Plans
Table 30. Ono Pharmaceutical Company Information, Head Office, and Major Competitors
Table 31. Ono Pharmaceutical Major Business
Table 32. Ono Pharmaceutical PD-L1 Biomarker Testing Product and Solutions
Table 33. Ono Pharmaceutical PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Ono Pharmaceutical Recent Developments and Future Plans
Table 35. Regeneron Company Information, Head Office, and Major Competitors
Table 36. Regeneron Major Business
Table 37. Regeneron PD-L1 Biomarker Testing Product and Solutions
Table 38. Regeneron PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Regeneron Recent Developments and Future Plans
Table 40. Innovent Company Information, Head Office, and Major Competitors
Table 41. Innovent Major Business
Table 42. Innovent PD-L1 Biomarker Testing Product and Solutions
Table 43. Innovent PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Innovent Recent Developments and Future Plans
Table 45. Hengrui Medicine Company Information, Head Office, and Major Competitors
Table 46. Hengrui Medicine Major Business
Table 47. Hengrui Medicine PD-L1 Biomarker Testing Product and Solutions
Table 48. Hengrui Medicine PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Hengrui Medicine Recent Developments and Future Plans
Table 50. Junshi Biosciences Company Information, Head Office, and Major Competitors
Table 51. Junshi Biosciences Major Business
Table 52. Junshi Biosciences PD-L1 Biomarker Testing Product and Solutions
Table 53. Junshi Biosciences PD-L1 Biomarker Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Junshi Biosciences Recent Developments and Future Plans
Table 55. Global PD-L1 Biomarker Testing Revenue (USD Million) by Players (2019-2024)
Table 56. Global PD-L1 Biomarker Testing Revenue Share by Players (2019-2024)
Table 57. Breakdown of PD-L1 Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in PD-L1 Biomarker Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key PD-L1 Biomarker Testing Players
Table 60. PD-L1 Biomarker Testing Market: Company Product Type Footprint
Table 61. PD-L1 Biomarker Testing Market: Company Product Application Footprint
Table 62. PD-L1 Biomarker Testing New Market Entrants and Barriers to Market Entry
Table 63. PD-L1 Biomarker Testing Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global PD-L1 Biomarker Testing Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global PD-L1 Biomarker Testing Consumption Value Share by Type (2019-2024)
Table 66. Global PD-L1 Biomarker Testing Consumption Value Forecast by Type (2025-2030)
Table 67. Global PD-L1 Biomarker Testing Consumption Value by Application (2019-2024)
Table 68. Global PD-L1 Biomarker Testing Consumption Value Forecast by Application (2025-2030)
Table 69. North America PD-L1 Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America PD-L1 Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America PD-L1 Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America PD-L1 Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America PD-L1 Biomarker Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America PD-L1 Biomarker Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe PD-L1 Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe PD-L1 Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe PD-L1 Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe PD-L1 Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe PD-L1 Biomarker Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe PD-L1 Biomarker Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific PD-L1 Biomarker Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America PD-L1 Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America PD-L1 Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America PD-L1 Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America PD-L1 Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America PD-L1 Biomarker Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America PD-L1 Biomarker Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa PD-L1 Biomarker Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 99. PD-L1 Biomarker Testing Raw Material
Table 100. Key Suppliers of PD-L1 Biomarker Testing Raw Materials
LIST OF FIGURES
Figure 1. PD-L1 Biomarker Testing Picture
Figure 2. Global PD-L1 Biomarker Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global PD-L1 Biomarker Testing Consumption Value Market Share by Type in 2023
Figure 4. PD-L1 (22C3)
Figure 5. PD-L1(28-8)
Figure 6. PD-L1 (SP142)
Figure 7. PD-L1 (SP263)
Figure 8. Other
Figure 9. Global PD-L1 Biomarker Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. PD-L1 Biomarker Testing Consumption Value Market Share by Application in 2023
Figure 11. Hospital Picture
Figure 12. Diagnostic Center Picture
Figure 13. Others Picture
Figure 14. Global PD-L1 Biomarker Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global PD-L1 Biomarker Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market PD-L1 Biomarker Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global PD-L1 Biomarker Testing Consumption Value Market Share by Region (2019-2030)
Figure 18. Global PD-L1 Biomarker Testing Consumption Value Market Share by Region in 2023
Figure 19. North America PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 22. South America PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 24. Global PD-L1 Biomarker Testing Revenue Share by Players in 2023
Figure 25. PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players PD-L1 Biomarker Testing Market Share in 2023
Figure 27. Global Top 6 Players PD-L1 Biomarker Testing Market Share in 2023
Figure 28. Global PD-L1 Biomarker Testing Consumption Value Share by Type (2019-2024)
Figure 29. Global PD-L1 Biomarker Testing Market Share Forecast by Type (2025-2030)
Figure 30. Global PD-L1 Biomarker Testing Consumption Value Share by Application (2019-2024)
Figure 31. Global PD-L1 Biomarker Testing Market Share Forecast by Application (2025-2030)
Figure 32. North America PD-L1 Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 33. North America PD-L1 Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 34. North America PD-L1 Biomarker Testing Consumption Value Market Share by Country (2019-2030)
Figure 35. United States PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe PD-L1 Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe PD-L1 Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe PD-L1 Biomarker Testing Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. France PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific PD-L1 Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific PD-L1 Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific PD-L1 Biomarker Testing Consumption Value Market Share by Region (2019-2030)
Figure 49. China PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. India PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 55. South America PD-L1 Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 56. South America PD-L1 Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 57. South America PD-L1 Biomarker Testing Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa PD-L1 Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa PD-L1 Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa PD-L1 Biomarker Testing Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 66. PD-L1 Biomarker Testing Market Drivers
Figure 67. PD-L1 Biomarker Testing Market Restraints
Figure 68. PD-L1 Biomarker Testing Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of PD-L1 Biomarker Testing in 2023
Figure 71. Manufacturing Process Analysis of PD-L1 Biomarker Testing
Figure 72. PD-L1 Biomarker Testing Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. PD-L1 Biomarker Testing Picture
Figure 2. Global PD-L1 Biomarker Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global PD-L1 Biomarker Testing Consumption Value Market Share by Type in 2023
Figure 4. PD-L1 (22C3)
Figure 5. PD-L1(28-8)
Figure 6. PD-L1 (SP142)
Figure 7. PD-L1 (SP263)
Figure 8. Other
Figure 9. Global PD-L1 Biomarker Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 10. PD-L1 Biomarker Testing Consumption Value Market Share by Application in 2023
Figure 11. Hospital Picture
Figure 12. Diagnostic Center Picture
Figure 13. Others Picture
Figure 14. Global PD-L1 Biomarker Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global PD-L1 Biomarker Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market PD-L1 Biomarker Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global PD-L1 Biomarker Testing Consumption Value Market Share by Region (2019-2030)
Figure 18. Global PD-L1 Biomarker Testing Consumption Value Market Share by Region in 2023
Figure 19. North America PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 22. South America PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 24. Global PD-L1 Biomarker Testing Revenue Share by Players in 2023
Figure 25. PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players PD-L1 Biomarker Testing Market Share in 2023
Figure 27. Global Top 6 Players PD-L1 Biomarker Testing Market Share in 2023
Figure 28. Global PD-L1 Biomarker Testing Consumption Value Share by Type (2019-2024)
Figure 29. Global PD-L1 Biomarker Testing Market Share Forecast by Type (2025-2030)
Figure 30. Global PD-L1 Biomarker Testing Consumption Value Share by Application (2019-2024)
Figure 31. Global PD-L1 Biomarker Testing Market Share Forecast by Application (2025-2030)
Figure 32. North America PD-L1 Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 33. North America PD-L1 Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 34. North America PD-L1 Biomarker Testing Consumption Value Market Share by Country (2019-2030)
Figure 35. United States PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe PD-L1 Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe PD-L1 Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe PD-L1 Biomarker Testing Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. France PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific PD-L1 Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific PD-L1 Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific PD-L1 Biomarker Testing Consumption Value Market Share by Region (2019-2030)
Figure 49. China PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. India PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 55. South America PD-L1 Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 56. South America PD-L1 Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 57. South America PD-L1 Biomarker Testing Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa PD-L1 Biomarker Testing Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa PD-L1 Biomarker Testing Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa PD-L1 Biomarker Testing Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE PD-L1 Biomarker Testing Consumption Value (2019-2030) & (USD Million)
Figure 66. PD-L1 Biomarker Testing Market Drivers
Figure 67. PD-L1 Biomarker Testing Market Restraints
Figure 68. PD-L1 Biomarker Testing Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of PD-L1 Biomarker Testing in 2023
Figure 71. Manufacturing Process Analysis of PD-L1 Biomarker Testing
Figure 72. PD-L1 Biomarker Testing Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
